EcoDrugPlus

Ensembl ID : ENSBGRG00000014249
Gene Symbol: -
Cross references: -
186 Possible Orthologues:

Ensembl ID : ENSBGRG00000014160
Gene Symbol: -
Cross references: -
299 Possible Orthologues:

Ensembl ID : ENSBGRG00000014049
Gene Symbol: -
Cross references: -
285 Possible Orthologues:

Ensembl ID : ENSBGRG00000013984
Gene Symbol: -
Cross references: -
163 Possible Orthologues:

Ensembl ID : ENSBGRG00000013578
Gene Symbol: -
Cross references: -
147 Possible Orthologues:

Ensembl ID : ENSBGRG00000013459
Gene Symbol: -
Cross references: -
265 Possible Orthologues:

Ensembl ID : ENSBGRG00000013035
Gene Symbol: -
Cross references: -
179 Possible Orthologues:

Ensembl ID : ENSBGRG00000013005
Gene Symbol: -
Cross references: -
400 Possible Orthologues:

Ensembl ID : ENSBGRG00000011604
Gene Symbol: -
Cross references: -
244 Possible Orthologues:

Ensembl ID : ENSBGRG00000011339
Gene Symbol: -
Cross references: -
292 Possible Orthologues:

Ensembl ID : ENSBGRG00000011562
Gene Symbol: -
Cross references: -
356 Possible Orthologues:

Ensembl ID : ENSBGRG00000001030
Gene Symbol: -
Cross references: -
72 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).